Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
Columbia University Irving Medical Center, New York, New York, United States
Research Site, Vinh, Vietnam
Saint Elizabeth Medical Center Edgewood, Edgewood, Kentucky, United States
Local Institution - 0369, Canton, Ohio, United States
Local Institution - 0382, Fortaleza, Ceará, Brazil
MD Anderson Cancer Center, Houston, Texas, United States
Maryland Proton Treatment Center, Baltimore, Maryland, United States
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
University of California San Diego (UCSD), San Diego, California, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Elchin Mansurov, Baku, Azerbaijan
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
Renji Hospital, Shanghai, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.